Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, today announced that it has received a two-year, $855,500 Small Business Technology Transfer (STTR) grant funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the American Recovery and Reinvestment Act (ARRA). The grant was awarded to Arcadia, in partnership with Washington State University (WSU), to help fund Phase II development of wheat varieties with reduced celiac disease-causing proteins… (Source: Health News from Medical News Today)

Further information:

Article source

Related posts:

1. Ablynx Receives Eur1.2 Million Grant To Further Advance Its Anti-Il-6r Programme, ALX-0061
2. Keystone Symposia awarded $1.37 million, 5-year NIH grant to fund ongoing diversity efforts
3. VCU Massey Cancer Center Receives NIH Grant
4. Sebelius Awards Over $10 Million To Utah To Test Innovations In Children’s Health Care
5. Siemens Hosts First In A Series Of Free Virtual Healthcare IT Conferences